North America AI in Clinical Trials Market by Trial Phase (Phase I, Phase II and Phase III), Type of Offering (Software and Services), Deployment Mode (Cloud-based and On-premises), Therapeutic Area (Oncological Disorders, Infectious Diseases, CNS Disorders, Metabolic Disorders, Immunological Disorders, Cardiovascular Disorders and Other Disorders), Technology Exposure, End-user and Countries – Trends and Forecast, 2026-2035